Anti-citrullinated SR-A Peptide (Anti-csp) Antibody as a Biomarker in Rheumatoid Arthritis (RA).

NCT07147127 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 81

Last updated 2025-08-28

No results posted yet for this study

Summary

1. To measure serum level of anticitrullinated SR-A peptide antibody (anti-CSP) in RA patients compared to healthy controls .
2. To assess the diagnostic performance of anti-CSP for RA specifically seronegative RA patients.
3. To evaluate correlation of serum anti-CSP level with disease activity and functional disability scores in RA patients.

Conditions

  • Rheumatoid Arthritis (RA)

Sponsors & Collaborators

  • Walaa sharif Eid Ahmed

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-31
Primary Completion
2027-12-31
Completion
2027-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07147127 on ClinicalTrials.gov